High Vista Strategies LLC Cytokinetics Inc Transaction History
High Vista Strategies LLC
- $241 Million
- Q2 2025
A detailed history of High Vista Strategies LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, High Vista Strategies LLC holds 68,652 shares of CYTK stock, worth $4.27 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
68,652
Previous 44,749
53.42%
Holding current value
$4.27 Million
Previous $1.8 Million
26.14%
% of portfolio
0.94%
Previous 0.78%
Shares
10 transactions
Others Institutions Holding CYTK
# of Institutions
384Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.1 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$913 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$746 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$487 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$397 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.86B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...